Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial

Planta Medica

Volumn 73, Issue 1, 2007, Pages 6-12

  Herrera Arellano, Armando ^a   Miranda Sánchez, Judith ^a   Ávila Castro, Pedro ^a   Herrera Álvarez, Sara ^a   Jiménez Ferrer, Jesús Enrique ^a   Zamilpa, Alejandro ^a   Román Ramos, Rubén ^b   Ponce Monter, Héctor ^b   Tortoriello, Jaime ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Antihypertensive; Complementary and alternative medicine; Hibiscus sabdariffa; Malvaceae; Standardized herbal medicinal product

Indexed keywords

ANTHOCYANIN; HERBACEOUS AGENT; HIBISCUS SABDARIFFA EXTRACT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

HIBISCUS SABDARIFFA; MALVACEAE;

EID: 33847771426     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957065     Document Type: Article

References (23)

1. Chobanian AV, Barkis GL, Black HR, Cushman WC, Gree LA, Izzo JL et al. Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42: 1206-52
2. Mudge GH, Weiner IM. Water, salts and ions. In: Goodman GA, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics Singapore: McGraw-Hill International editions, 1992: 682-707
3. Argueta VA, Cano AL, Rodarte ME. Atlas de las plantas de la Medicina Tradicional Mexicana. México: Instituto Nacional Indigenista, 1994: 849-50
4. The Complete German Commission E Monographs. Therapeutic guide to herbal medicines. Texas: American Botanical Council, 1998: 336
5. Jonadet M, Bastide J, Bastide P, Boyer B, Carnat AP, Lamaison JL. In vitro enzyme inhibitory and in vivo cardioprotective activities of hibiscus (Hibiscus sabdariffa L.). J Pharm Belg 1990; 45: 20-4
6. Ali MB, Salih WM, Mohamed AH, Homeida AM. Investigation of the antispasmodic potential of Hibiscus sabdariffa calyces. J Ethnopharmacol 1991; 31: 249-57
7. Adegunloye BJ, Omoniyi JO, Owolabi OA, Ajagbonna OP, Sofola OA, Coker HA. Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats. Afr J Med Med Sci 1996; 25: 235-8
8. Onyenekwe PC, Ajani EO, Ameh DA, Gamaniel KS. Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that in Wistar rats. Cell Biochem Funct 1999; 17: 199-206
9. Odigie IP, Ettarh RR, Adigun SA. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats. J Ethnopharmacol 2003; 86: 181-5
10. Salah AM, Gathumbi J, Vierling W. Inhibition of intestinal motility by methanol extracts of Hibiscus sabdariffa L. (Malvaceae) in rats. Phytother Res 2002; 16: 283-5
11. Frank T, Janssen M, Netzel M, Strass G, Kler A, Kriesl E et al. Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. extract. J Clin Pharmacol 2005; 45: 203-10
12. Akindahunsi AA, Olaleye MT. Toxicological investigation of aqueous-methanolic extract of the calyces of Hibiscus sabdariffa L. J Ethnopharmacol 2003; 89: 161-4
13. Haji Faraji M, Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol 1999; 65: 231-6
14. Herrera-Arellano A, Flores-Romero S, Chavez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine 2004; 11: 375-82
15. The joint national committee on prevention, detection, evaluation and treatment of high blood pressure. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med, 1997; 157: 2413-46
16. Chase MP, Fiarman GS, Scholz FJ, MacDermott RP. Angioedema of the small bowel due to an angiotensin-converting enzyme inhibitor. J Clin Gastroenterol 2000; 31: 254-7
17. Wright JTJr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE et al. ALLHAT Collaborative Research Group. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005; 293: 1595-608
18. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens 2005; 7: 346-51
19. Weiner IM. Diuretics and other agents employed in the movilization of edema fluid. In: Goodman GA, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics Singapore: McGraw-Hill International editions, 1992: 713-31
20. Reyes AJ, Leary WP, Crippa G, Maranhao MF, Hernandez-Hernandez R. The aldosterone antagonist and facultative diuretic eplerenone: a critical review. Eur J Intern Med 2005; 16: 3-11
21. Burgess ED, Lacourciere Y, Ruilope-Urioste LM, Oparil S, Kleiman JH, Krause S et al. Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Clin Ther 2003; 25: 2388-404
22. El-Saadany SS, Sitohy MZ, Labib SM, El-Massry RA. Biochemical dynamics and hypocholesterolemic action of Hibiscus sabdariffa (Karkade). Nahrung 1991; 35: 567-76
23. Chen CC, Hsu JD, Wang SF, Chiang HC, Yang MY, Kao ES et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J Agric Food Chem 2003; 51: 5472-7